‘A new shareholder for Prevent Vaccins’:
After four intense years of collaboration, we have successfully sold our shares in Prevent Vaccins to European Life Care Group, backed by Inflexion. Navigating through the challenges of the COVID-19 pandemic, we experienced both highs and lows together. Despite the significant disruptions caused by the pandemic, including severely limited international travel, we managed to keep the company stable.
Following these difficult years, the company emerged stronger than ever. Given the substantial interest from the market, we determined that this was the right time for a new shareholder to lead the company into its next phase of growth.
